Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026)
Lifeward (LFWD) reported Net Income towards Common Stockholders of -$10.8 million for Q1 2026, down 123.27% on a YoY basis from $46.4 million in Q1 2025, and down 101.81% sequentially from -$5.3 million in Q4 2025.
Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 12 years of Net Income towards Common Stockholders data on file, last reported at -$10.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 123.27% year-over-year to -$10.8 million; the trailing twelve-month figure through Mar 2026 stood at -$25.9 million (up 5.92% YoY), and the FY2025 full-year result was -$19.9 million, up 31.19% from the prior year.
- Net Income towards Common Stockholders slipped to -$10.8 million in Q1 2026, from -$5.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$3.1 million in Q3 2024 to a low of -$15.3 million in Q4 2024.
- A 5-year average of -$6.0 million and a median of -$5.3 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders tumbled 170.93% in 2024 and jumped 65.0% in 2025, its largest moves.
- Tracing LFWD's Net Income towards Common Stockholders over 5 years: stood at -$5.3 million in 2022, then decreased by 6.14% to -$5.6 million in 2023, then plunged by 170.93% to -$15.3 million in 2024, then jumped by 65.0% to -$5.3 million in 2025, then sank by 101.81% to -$10.8 million in 2026.
- Business Quant data shows LFWD's Net Income towards Common Stockholders at -$10.8 million in Q1 2026, -$5.3 million in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Lifeward | 11.08 Mn | -338,049.92 | 1.34 Mn | -10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -5.35 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | -5.64 Mn |
| Sep 30, 2023 | -7.53 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -5.46 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | -4.35 Mn |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -3.14 Mn |